Showing 1 - 3 results of 3 for search 'Mark N. Stein', query time: 0.01s Refine Results
  1. 1
    Emapalumab for severe cytokine release syndrome in solid tumor CAR-T: a case report

    Emapalumab for severe cytokine release syndrome in solid tumor CAR-T: a case report by Tyler Ruemmele, Rodney Macedo, Rodney Macedo, Mark N. Stein, Hei Ton Chan, Markus Y. Mapara, Markus Y. Mapara, Céline F. Jacquemont, Ran Reshef, Ran Reshef

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Safety and pharmacokinetics of veliparib extended‐release in patients with advanced solid tumors: a phase I study

    Safety and pharmacokinetics of veliparib extended‐release in patients with advanced solid tumors: a phase I study by Theresa L. Werner, Jasgit Sachdev, Elizabeth M. Swisher, Martin Gutierrez, Muaiad Kittaneh, Mark N. Stein, Hao Xiong, Martin Dunbar, Danielle Sullivan, Philip Komarnitsky, Mark McKee, Antoinette R. Tan

    Published 2018-06-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial

    PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a phase 1 dose escalation trial by Mark N. Stein, Ecaterina E. Dumbrava, Benjamin A. Teply, Usama S. Gergis, Martin E. Guiterrez, Ran Reshef, Sumit K. Subudhi, Céline F. Jacquemont, Joseph H. Senesac, J. Henri Bayle, Charity D. Scripture, Monica S. Chatwal, Mehmet A. Bilen, Walter M. Stadler, Carlos R. Becerra

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: